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Abstract 
A NADP+ dependent dehydrogenase activity on 3-glutathionyl-4-hydroxynonanal (GSHNE) was 
purified to electrophoretic homogeneity from a line of human astrocytoma cells (ADF). Proteomic 
analysis identified this enzymatic activity as associated with carbonyl reductase 1 (E.C. 1.1.1.184). 
The enzyme is highly efficient at catalyzing the oxidation of GSHNE (KM33 µM,kcat.405 min-1), as 
it is practically inactive towards trans-4-hydroxy-2-nonenal (HNE) and other HNE-addicted thiol-
containing amino acid derivatives. Combined mass spectrometry and nuclear magnetic resonance 
spectroscopy analysis of the reaction products revealed that carbonyl reductase oxidizes the 
hydroxyl group of GSHNE in its hemiacetal form, with the formation of the corresponding 3-
glutathionyl-nonanoic--lactone. The relevance of this new reaction catalyzed by carbonyl 
reductase 1 is discussed in terms of HNE detoxification and the recovery of reducing power. 
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 Introduction 
The pathophysiological effects of oxidative stress on cells and tissues are assumed to be related, at 
least in part, to endogenous lipid peroxidation and to the highly reactive molecules consequently 
produced, of which the most abundant is trans-4-hydroxy-2-nonenal (HNE) [1-3]. HNE is 
generated as a racemic mixture of 4R- and 4S- enantiomers primarily from the peroxidation of -6 
polyunsatured fatty acids [4].It may account for more than 95% of the enals produced [5,6]. Basal 
HNE concentrations in tissue and plasma range from 0.8 to 2.8 µM [7], and there is evidence of 
increased levels up to 4.5 mM in peroxidizing membranes under oxidative stress conditions [8].  
HNE plays an important role in the pathogenesis of several diseases, including atherosclerosis and 
Alzheimer's disease [6,9,10]. The toxicity of HNE depends on its high chemical reactivity, which is 
associated with the presence of an aldehydic group, a double bond and a secondary alcohol at the 
chiral centre C4 [11]. HNE can react with nucleophiles via 1,2 and 1,4 addition [7,12,13]. The main 
protein modification associated with HNE occurs via 1,4-Michael addition with Cys, Lys and His 
residues [7,12,14]. A number of proteins, including albumin, amyloid beta peptide, alpha-synuclein, 
aldose reductase and several glutathione S-transferase (GST) isoforms, have been reported to be 
covalently modified in vitro by HNE [15-25]. On the other hand, the 1,2-addition of the carbonyl 
group to the primary amine of Lys has also been reported, which generates the corresponding Schiff 
base [13,24]. 
As a signaling molecule, HNE is involved in modulating in a concentration-dependent manner 
several cellular processes, such as proliferation, differentiation and apoptosis. High concentrations 
of HNE have thus been reported to cause cell cycle arrest [26], differentiation [27]and apoptosis 
[28,29].Lower concentrations, at least in some cell types, appear to induce proliferation [30]. 
Intracellular control of HNE levels is thus required in order to modulate the cell cycle. 
HNE metabolism involves reducing aldehyde to the corresponding 1,4 dihydroxynonene (DHN) by 
aldose reductase [31,32] and alcohol dehydrogenase [33,34] or oxidating aldehyde to the 4- 
hydroxynonenoic acid (HNA) by aldehyde dehydrogenase [35-37]. However, the formation of the 
3-glutathionyl-4-hydroxynonanal (GSHNE) is considered as the main pathway of the HNE 
metabolism [38-40]. GSHNE, which is present in solution essentially (95%) in its cyclic hemiacetal 
form [7,41], can be produced both in a spontaneous reaction between HNE and glutathione (GSH), 
and in a reaction efficiently catalyzed by GST [7,42]. Of the isoforms of GST in mammalian 
tissues, a subgroup of the -class isozymes shows the highest catalytic efficiency for HNE [43-46]. 
As GSHNE is the most significant HNE derivative, its metabolism represents the main pathway for 
the control of HNE levels. Depletion of intracellular GSH by buthionine sulfoximine or by 
oxidative insult reduces GSHNE levels with a consequent increase in free HNE amounts and in 
cellular toxicity [47,48]. However, since GSHNE is an inhibitor of GST activity, the adduct needs 
to be removed from the cell by extrusion and/or intracellular metabolism [49,50]. 
As with HNE, GSHNE is susceptible to both oxidative and reductive transformations. Thus, aldose 
reductase reduces GSHNE to 1,4-dihydroxynonane-glutathione (GSDHN) [32], which has been 
shown to be involved in the proliferation and inflammation cell signaling cascades [51-53]. On the 
other hand, GSHNE can be oxidized by NAD-dependent aldehyde dehydrogenase to 4-
hydroxynonanoic acid-glutathione (GSHNA) [54] or its lactone form [55]. These oxidized 
derivatives can be further metabolized by cytochrome P450 4A, with the subsequent production of 
-hydroxylated and carboxylated metabolites [38,55-57]. Finally, the glutathione moiety of these 
adducts can be transformed into mercapturic acid in the kidney and the resulting metabolites are 
excreted into urine [58-60]. 
The present study on human astrocytoma ADF cells highlights a highly efficient and specific 
dehydrogenase activity of carbonyl reductase 1 (CBR1) on GSHNE but not on HNE, , which was 
never recognized and reported before. This novel activity of CBR1 is here discussed in terms of 
detoxification and recovery of cell reducing power. 
 
 
Materials and Methods 
Materials 
GSH, Cys, CysGly, GluCys, BSA, SDS, 5,5’-dithiobis- (2-nitrobenzoic acid) (DTNB), trans-2-
nonenal, NADP+, NADPH, 9,10-PQ, and sequencing-grade trypsinwere purchased from Sigma 
Aldrich (St. Louis, MO, USA). 4-Oxo-nonenal (ONE), prostaglandin B1 (PGB1) and 4-hydroxy-2-
nonenal mercapturic acid were purchased from Cayman Chemicals (Ann Arbor, MI, USA) 
Whatman DEAE-cellulose (DE-52) and Sephacryl S200 were purchased from GE Healthcare (Little 
Chalfont, UK). Blue Sepharose and Bradford reagent were purchased from Bio-Rad (Hercules, CA, 
USA). YM10 membranes (10kDa cut-off) were purchased from Amicon Millipore (Darmstadt, 
Germany). RPMI 1640, penicillin, streptomycin, glutamine and foetal bovine serum (FBS) were 
obtained from Lonza (Basel, Switzerland). Dialysis tubing (10kDa cut-off) was purchased from 
Spectrum Laboratories Inc (Rancho Dominguez, CA, USA). All inorganic chemicals were of 
reagent grade from BDH (VWR international ltd, Poole Dorset, UK). All solvents were HPLC-
grade from J.T. Baker Chemicals (USA). 
 
Cell cultures 
ADF cells were kindly provided by Dr. W. Malorni, Istituto Superiore di Sanità, Rome, Italy.ADF 
cells were cultured on 10 cm diameter dishes in RPMI1640 medium supplemented with 10% (v/v) 
fetal bovine serum, 50 mU/mL penicillin/streptomycin and 2 mM glutamine at 37 °C, in a 
humidified 5% CO2 atmosphere. Cell plates were washed with a phosphate buffer solution (PBS) 
(0.08% w/v NaCl, 0.002% w/v KCl, 0.002% w/v KH2PO4, 0.006% Na2HPO4), cells were harvested 
with a scraper and stored as suspensions in PBS (8 x 107 cells/mL) at -80°C until use. 
 
Assay of carbonyl reductase 
The activity of CBR1 was determined at 37°C using GSHNE as the substrate to be oxidized. The 
reaction was monitored following the increase in absorbance at 340 nm due to the reduction of 
NADP+(340 = 6.22 mM-1.cm-1). The reaction mixture contained 0.1 mM GSHNE, 0.18 mM NADP+ 
in 50 mM sodium phosphate buffer pH 8.4. One unit of enzyme activity is the amount that catalyzes 
the conversion of 1 µmol of substrate/min in the above assay conditions.  
The dehydrogenase activity of CBR1 was evaluated as described above on different substrates at the 
reported concentrations (see Results). In the case of PGB1, 2% ethanol was present in the assay 
mixture. The NADPH-dependent reductase activity of CBR1was determined in the conditions 
described above on different substrates at the reported concentrations, following the decrease in 
absorbance at 340 nm due to the oxidation of 0.18 mM NADPH. In the case of 9,10-PQ and 
menadione, the assay mixture contained DMSO at a fixed final concentration of 2% and 1.25% 
(v/v), respectively. DMSO and ethanol (2% final concentration) had no effect on the activity of 
CBR1, as measured in standard conditions. KM and kcat values were determined by linear regression 
analysis of kinetic data of double reciprocal plots using GraphPad software. The kcat values were 
calculated on the basis of a MW of 31 kDa. 
 
Purification of the GSHNE NADP+ dependent dehydrogenase activity.  
A GSHNE-NADP+-dependent dehydrogenase (GSHNE-DH) activity was purified from ADF cells. 
All procedures were carried out at 4°C. Cell lysates were obtained through a freezing and thawing 
protocol, followed by a centrifugation at 10,000 x g for 30 min. The supernatant was diluted 1:1 
with4 mM DTT in10 mM sodium phosphate pH 7, and referred to as the “crude extract “.The latter 
was applied onto a DE-52 column (2.5x 9 cm) which was eluted with2 mM DTT in 10 mM sodium 
phosphate pH 7 buffer (SB) at a flow rate of 17 mL/h, collecting 3 mL fractions. SB containing 0.2 
M NaCl was then applied. Fractions displaying activity were pooled and concentrated using an 
Amicon YM10 membrane. Thus, the concentrated protein solution was applied on a Sephacryl 
S200 column (1.6 x 80 cm) which was eluted with SB containing 0.1 M NaCl, at a flow rate of 20 
mL/h, collecting 1.7 mL fractions. The active fractions were pooled and applied on a Blue-
Sepharose column (1.2 x 8 cm), equilibrated with SB at 10 mL/h; column elution was performed 
with SB supplemented with 0.1 mM NADP+  and NaCl at different concentrations (see details on 
Supplementary Materials) collecting 1.5 mL fractions. Fractions displaying GSHNE-DH activity 
were pooled, concentrated to a protein concentration of 0.01 mg/mL using an Amicon YM10 
ultrafiltration membrane, and stored at 4°C, until used.  
 
Synthesis of aldehydes.  
Diethyl acetals of HNE and 4-hydroxy-2-noninal were prepared according to a previous procedure 
[61]. 4-hydroxy-2-nonanal diethyl acetal was prepared by catalytic hydrogenation (PtO in ethyl 
acetate) of 4-hydroxy-2-noninal diethyl acetal [62]. Free aldehydes were prepared by acid 
hydrolysis (pH 3.0) of the diethylacetals for 1 h, at 4°C.The concentration of HNE and trans-2-
nonenal was determined by measuring the absorbance at 224 nm using an extinction coefficient of 
13.7 mM-1.cm-1 [61]. 
 
Preparation of thiol-adducts.  
GSHNE, CysHNE, CysGlyHNE, and GluCysHNE were prepared by incubating 1mM HNE in the 
presence of 1.5mM of each thiol containing compound in 50 mM sodium phosphate buffer pH 7.4, 
at 37 °C, for 1h, followed by an overnight incubation at 4 °C. The reaction was monitored by 
following the consumption of both HNE, by checking the absorbance at 224 nm, and of the 
corresponding reduced thiols by the Ellman assay [63]. Taking into account the spontaneous 
oxidation of the SH moiety, a stoichiometric consumption of thiols and HNE was observed in all 
cases. In addition, the residual HNE accounted for no more than 10% of the initial value. GS-
nonanal was prepared by incubating trans-2-nonenal with GSH in the same conditions described 
above. In all cases, resulting derivatives were stored at -80°C, until used. 
 
Proteomic identification of the GSHNE NADP+ dependent dehydrogenase activity.  
A protein sample exhibiting GSHNE-DH activity was analyzed by SDS-PAGE; protein bands 
present within the gel were excised, minced, in gel-reduced with DTT, S-alkylated with 
iodoacetamide, and digested with trypsin [64]. Resulting peptide mixtures were desalted with Zip-
TipC18 (Millipore) devices, and analyzed for protein identification by nLC-ESI-LIT-MS/MS, using 
an LTQ XL mass spectrometer (Thermo, USA) equipped with a Proxeon nanospray source 
connected to an Easy-nanoLC (Thermo, USA) [65].Peptides were separated on an Easy C18 column 
(100 mm × 0.075 mm, 3 m) (Thermo, USA);mobile phases were 0.1% v/v formic acid (solvent A) 
and 0.1% v/v formic acid in acetonitrile (solvent B), running at total flow rate of 300 nL/min. 
Linear gradient was initiated 20 min after sample loading; solvent B ramped from 5% to 35% over 
45 min, from 35% to 60% over 10 min, and from 60% to 95% over 20 min. Spectra were acquired 
in the range m/z 400-2000. Peptide samples were analyzed under collision-induced dissociation-
MS/MS data-dependent product ion scanning procedure, enabling dynamic exclusion (repeat count 
1 and exclusion duration 60 s) over the three most abundant ions. Mass isolation window and 
collision energy were set to m/z 3 and 35%, respectively. 
Raw data from nLC-ESI-LIT-MS/MS analysis were searched with a MASCOT search engine 
(version 2.2.06, Matrix Science, U.K.) against an updated UniProtKB non-redundant (2014/04/16) 
database. Database searching was performed by using a mass tolerance value of 2.0 Da for 
precursor ion and 0.8 Da for MS/MS fragments, trypsin as proteolytic enzyme, a missed cleavage 
maximum value of 2, and Cys carbamidomethylation and Met oxidation as fixed and variable 
modifications, respectively. Other MASCOT parameters were kept as default. Candidates with at 
least 2 unique assigned peptides with an individual peptide expectation value <0.05 (corresponding 
to a confidence level for peptide identification >95%) were considered confidently identified. 
Definitive peptide assignment was always associated with manual spectra verification. 
 
Mass spectrometry analysisof the reaction products deriving from the CBR1-catalyzed oxidation of 
GSHNE.  
A sample containing 102 µM GSHNE, 180 µM NADP+, 62 µM GSH, 8.9 µM HNE in 30 mM 
phosphate buffer, pH 8.4, was incubated with 3.6 mU/mL CBR1, at 37 °C. The extent of reaction 
was monitored on a time-course basis by sampling the reaction mixture at different reaction times. 
Samples 1 to 4 were withdrawn at 0, 10, 40 and 80 min of incubation, respectively; sample 5 
corresponded to 75 min of further incubation of the mixture after supplementation with additional 
enzyme (2.5 mU/mL). In parallel, identical samples containing isolated components in 30 mM 
phosphate buffer, pH 8.4, i.e. 102 µM GSHNE, 180 µM NADP+, 62 µM GSH, 8.9 µM HNE, 3.6 
mU/mL CBR1, or mixtures of that were incubated at 37 °C, as reported above. After sampling, 
samples were immediately frozen in dry ice, lyophilized and stored at -80 °C, until used. Samples 
were then solubilized in 0.1% formic acid and analyzed by nLC-ESI-LIT-MS/MS, as described 
above. In this case, solvent B ramped from 5% to 35% over 10 min, from 35% to 95% over 2 min. 
Raw data from nLC-ESI-LIT-MS/MS analyses were manually interpreted and assigned to specific 
glutathione derivatives. 
A semi-quantitative measurement of the reaction products was obtained by analyzing the same 
samples with nLC-ESI-LIT-MS as described above, with the unique exception that 
chromatographic runs were acquired only in MS scan mode, without ion fragmentation [66, 67]. In 
this case, extraction and integration of the LC-MS peak areas corresponding to the reagent GSHNE 
and to the observed reaction products were performed in the same total ion chromatogram; the 
Genesis algorithm in the Xcalibur software (Thermo, USA) was used to this purpose. Since 
different ionization properties were expected for the different molecules, a measurement of their 
relative amount was obtained by extracting and integrating peak areas corresponding to these 
compounds and to Met-Arg-Phe-Ala (Sigma, USA); the latter peptide was used as internal reference 
and spiked in all samples at the same concentration before MS analysis. Semi-quantitative 
evaluation of the modification extent was then determined by calculating the ratio: Peak Areaspecies of 
interest/Peak Areainternal reference peptide. This procedure was applied to all samples reported above by 
performing experiments in quintuplicate. 
 
NMR spectroscopy measurements.  
For acquisition of NMR spectra, reaction samples reported in the previous section were dissolved in 
30 mM sodium phosphate buffer, pH 8.4, and95% 1H2O, 5% 2H2O (Cortecnet, Voisins-Le-
Bretonneux, France). All spectra were recorded on a 600 MHz Bruker Avance III spectrometer 
(Bruker BioSpin GmbH, Rheinstetten, Germany) equipped with a CryoProbe™. One-dimensional 
(1D) 1H-NMR spectra were collected at 300 K with the excitation sculpting pulse sequence [68] to 
suppress the water resonance. We used a double-pulsed field gradient echo, with a soft square pulse 
of 4 ms at the water resonance frequency, and the gradient pulses of 1 ms each in duration, adding 
128 transients of 64k complex points, with an acquisition time of 4 s/transient. Time-domain data 
were all zero-filled to 128k complex points, and prior to Fourier transformation, an exponential 
multiplication of 0.6 Hz was applied. Two-dimensional (2D) clean total correlation spectroscopy 
(TOCSY) spectra [69] were recorded using a standard pulse sequence and incorporating the 
excitation sculpting sequence for water suppression. In general, 360 equally spaced evolution-time 
period t1 values were acquired, averaging 16 transients of 2048 points with 6024 Hz of spectral 
width. Time-domain data matrices were all zero-filled to 4096 points in both dimensions, and prior 
to Fourier transformation a Lorentz-to-Gauss window was applied for both t1 and t2 dimensions for 
all the experiments. Both homonuclear 1D and 2D spectra were referred to 0.10 mM TSP, assumed 
to resonate at  = 0.00 ppm in both dimensions. 
For the natural abundance of 2D 1H-13C Heteronuclear Single Quantum Coherence (HSQC) spectra, 
we used an echo-antiecho phase sensitive pulse sequence using adiabatic pulses for 
decoupling[70].One hundred-twenty eight equally spaced evolution time period t1 values were 
acquired, averaging 64 transients of 2048 points and using GARP4 for decoupling. The final data 
matrix was zero-filled to 4096 in both dimensions, and apodized before Fourier transformation by a 
shifted cosine window function in t2 and in t1. Linear prediction was also applied to extend the data 
to twice their length in t1. Spectra were referred to internal TSP, assumed to resonate at  = 0.00 
ppm in both dimensions. 
 
Other methods. 
Protein determination was performed according to Bradford [71]. SDS-PAGE was performed 
according to Laemmli [72]; gels were stained by the silver stain technique [73]. The activity of 
aldose reductase, glucose-6-phosphate dehydrogenase, isocitrate dehydrogenase and 6-P gluconate 
dehydrogenase were determined at 37°C, according to [74-77], respectively. 
 
RESULTS 
Enzyme Purification and characterization. A marked NADP+ reduction was observed when ADF 
cell crude extracts were incubated in the presence of GSHNE. This dehydrogenase 
activity(GSHNE-DH) was purified approximately 250-fold with an overall yield of 26%. The 
purification procedure included ionic exchange, exclusion and affinity chromatography. During the 
purification, attention was focused on discriminating between known NADP(H) oxidoreductase 
activities and GSHNE-DH activity. The ionic exchange step was able to separate both glucose 6-
phosphate dehydrogenase and isocitric dehydrogenase from GSHNE-DH activity. The gel filtration 
chromatographic step separated the 6-phosphogluconate dehydrogenase from the GSHNE-DH 
which was significantly smaller in size (approximately 30 kDa). Finally, GSHNE-DH was separated 
from aldose reductase by the affinity chromatography step, giving rise to a pure GSHNE-DH 
preparation characterized by a protein doublet in SDS-PAGE, with an apparent molecular weight of 
31-32 kDa (see the Supplementary Figures 1S-4S for chromatographic elution profiles and SDS-
PAGE). The pure enzyme preparation (11 U/mg protein) was stable for at least two weeks in SB 
containing 0.1 mM NADP+ and 1.5 M NaCl, at 4°C. Before kinetic analysis, the enzyme was 
subjected to an overnight dialysis on dialysis tubing (cut off 10 kDa) against 10 mM sodium 
phosphate pH 7.0.  
Both bands present in SDS-PAGE of the GSHNE-DH preparation (Supplementary Figure 4S) were 
subjected to independent proteomic analyses. Both gave the same identification results, proving 
their nature as 15-hydroxyprostaglandin dehydrogenase (E.C. 1.1.1.184), also referred to as 
carbonyl reductase 1 (CBR1). nLC-ESI-LIT-MS/MS mapping experiments provided identical 
results for both bands, with the exception of a peptide component uniquely observed in the case of 
the high mass-migrating protein component, which was associated with a CBR1 form containing a 
carboxyethyl mojety at Lys238 (see the Supplementary Fig. 5S for the MS/MS spectrum of the 
modified peptide). This component was absent in the low mass-migrating protein component, which 
conversely showed the presence of the corresponding non-modified counterpart (data not shown). 
 
NADP(H) dependent activity of CBR1fromADF cells. The NADPH-dependent reductase activity 
of the purified CBR1 was tested on a number of molecules, including classical substrates of this 
enzyme (Table 1). Of these, only 9,10-PQ, menadione and ONE, in the order of decreasing 
effectiveness, were reduced by the enzyme, while different alkenals and their glutathionyl 
derivatives (including GSHNE) were completely unaffected. The kinetic parameters evaluated for 
the NADPH-dependent reduction of 9,10-PQ (1.8 ± 0.2 µM and 101 ± 4 min-1, for KM and kcat, 
respectively, Fig. 1) were in accordance with the literature data reported for human CBR1 [78]. 
Also the NADP+-dependent dehydrogenase activity of the enzyme was tested on a number of 
molecules (Table 2), including PGB1, a distinctive substrate for the dehydrogenase action of CBR1 
[79] and GSHNE, which was used in this study to monitor enzyme purification. Of the tested 
substrates, only GSHNE and PGB1 were transformed. No effect on the enzyme activity was 
observed when either N-acetyl cysteine or buthionine sulfoximine were present in the assay mixture 
at the final concentration of 0.5 mM. 
The reaction was strictly dependent on NADP+ since NAD+ was completely ineffective as a 
cofactor for all the tested substrates. The same pattern of dehydrogenase activity towards pyridine 
cofactors and different substrates was observed with a recombinant CBR1 obtained from RNA 
isolated from ADF cells. It is worth noting that the cDNA sequence obtained for the ADF enzyme 
completely matched with the human wild type sequence. 
 
NADP+-dependent GSHNE-DH activity of CBR1. A comparative kinetic analysis between 
GSHNE and PGB1 revealed that the former was a far better substrate for the enzyme than the one 
considered as its distinctive substrate (Fig. 2). In the case of GSHNE oxidation, a KM of 33 ± 2 µM 
and a kcat of 405 ± 7 min-1 were measured; for PGB1 a KM of 91 ± 8 µM and a kcat of 60 ± 2 min-1 
were obtained. Thus, the specificity constant (ks) for GSHNE (12.3 x 103 ± 0.7 x 103 mM-1 min-1) 
was approximately 18 fold higher than for PGB1 (0.7 x103 ± 0.1 x 103 mM-1 min-1). In addition, 
while a 40% decrease in activity was observed with PGB1 when the pH of the reaction buffer was 
decreased from 8.4 to 7.4, no changes in activity (a less than 10% decrease) were observed when 
GSHNE was used as substrate in the pH range 8.4-6.4. 
The effectiveness of NADP+ as a cofactor for the GSHNE oxidation is reported in Fig. 3. CBR1 
displayed a KM value for the cofactor of 11 ± 2µM and a kcat value of 367 ± 17 min-1, which 
accounted for a ks value equal to 33.4 x 103 ± 5.9 x 103 mM-1min-1. Figure 3 also reports the effect 
of both NAD+ and NADPH on the GSHNE oxidation. There was an apparent competitive inhibitory 
effect of NADPH on the dehydrogenase reaction (Ki value approximately equal to 6 µM). In 
addition, NAD+, which cannot be used as a cofactor by the enzyme, failed to interfere with the 
NADP+ dependent dehydrogenase reaction. 
 
Identification of the reaction products by nLC-ESI-LIT-MS/MS. Analysis of the reaction products 
of the GSHNE oxidation catalyzed by CBR1 was performed on samples taken from a 
transformation time curve of the substrate at 37°C, as deriving from a mixture containing 102 µM 
GSHNE, 180 µM NADP+ and 3.6 mU/mL of purified CBR1in 30 mM sodium phosphate pH 8.4. 
The mixture also contained GSH and HNE (62 µM and 8.9 µM, respectively) as residual reagents 
of the GSHNE preparation; both compounds had been previously verified not to affect the enzyme 
activity. The increase in absorbance at 340 nm (linked to NADP+ reduction) was monitored; 
samples at 0, 10, 40 and 80 min of incubation (samples 1 to 4, respectively) were withdrawn as 
reported in the experimental section. Under these conditions, the extent of NADP+ reduction 
accounted for approximately 40 µM, which increased to 52 µM after 75 min of further incubation 
of the mixture after supplementation with additional 2.5 mU/mL of the enzyme (sample 5). All 
samples were then analyzed by nLC-ESI-LIT-MS/MS and NMR. 
nLC-ESI-LIT-MS/MS analysis of standard compounds and the reaction mixtures mentioned above 
(samples 1 to 5) identified initial reagents and glutathione derivatives that progressively appeared 
after the addition of CBR1. A number of peaks showing the same mass value were observed in the 
nLC-ESI-LIT-MS/MS profile that, considering the occurrence of various chiral centers in these 
HNE-addicted glutathione derivatives, were associated with pairs of unresolved diastereomers (see 
the Supplementary Fig. 6S for the total ion current and ion-extracted chromatograms of sample 4), 
as already reported in the case of GSHNE [80,81] and other HNE-thiol adducts [82,83]. The most 
representative peaks referred to GSHNE (exp. and theor. MH+ values at m/z464.18 and 464.21, 
respectively) (Fig. 4A), which was originally present in the mixture before CBR1 addition and 
decreased during the incubation with the enzyme (Fig. 5), and to glutathione derivatives showing an 
experimental MH+ signal at about m/z462.23, namely glutathionyl-4-ketononanal or glutathionyl-4-
hydroxynonanoic acid (GSHNA) -lactone (theor. MH+ value at m/z462.19) (Fig. 4B), which 
increased on a time-course basis (Fig. 5). Less significant was the generation of GSHNA in its 
acyclic form (exp. and theor. MH+ values at m/z480.25 and 480.20, respectively) (Fig. 4C), and 
even less the generation of the double-centered oxidative product glutathionyl-4-ketononanoic acid 
(exp. and theor. MH+ values at m/z478.19 and 478.19, respectively) (Fig. 5). Semi-quantitative 
measurements of the reaction mixtures assumed that all HNE-addicted glutathione derivatives 
reported in this study might present the same ionization tendency. According to the nature of the 
products observed during time-course nLC-ESI-LIT-MS/MS analysis of the incubation mixtures, a 
reaction pathway catalyzed by CBR1 was proposed (Fig. 6). 
 
Characterization of the reaction products by NMR analysis. The nature of the initial reagents and 
of the resulting product(s) was finally demonstrated by NMR analysis. We firstly analyzed single 
products and their mixtures without CBR1. Resonances were assigned using 2D homo- and 
heteronuclear experiments. In the GSHNE/GSH/HNE and GSHNE-GSH-HNE-NADP+ spectra 
(Fig. 7), the envelope centered at 5.57 ppm was assigned to 1-H of GSHNE and was consistent with 
the occurrence of the cyclic hemiacetal form of HNE adducts [81] under the experimental 
conditions we used. Four peaks (I at 5.59 ppm, II at 5.53 ppm, III at 5.50 ppm, and IV at 5.47 ppm) 
were identified. They stem from the four major diastereomers of the spontaneous reaction of 
racemic HNE with GSH. Considering the chiral centers, there are eight potential GSHNE 
diastereomers in total, and it is possible that each of the four peaks constitute a pair of unresolved 
diastereomers [81]. The remaining proton signals of GSHNE were also identified and are indicated 
in Fig. 7 (middle and upper spectra). 
Analysis of the low field region of the reaction time course in phosphate buffer (Fig. 8) indicated 
that, in the presence of CBR1, peaks I-IV originating from proton 1 of GSHNE started to be 
modified after 10 min, with all NADPH peaks appearing and the corresponding reduction of 
NADP+ signals. After 80 min, peaks II, III and IV almost disappeared, while peak I was still 
partially present, with the doublet at 5.50 ppm originating from NADPH. After 155 min (top 
spectrum),peak I was barely visible. Analysis of the high-field region between 2.5 and 2.3 ppm 
clarified the presence of the GSHNA δ-lactone (Fig. 9). In fact, formation of lactone requires 
disappearance of proton 1(Fig.6); this can be followed in the evolution of the GSHNE signals 
labeled 2 in Fig. 9. The ongoing reaction from 10 to 155 min indicated that the multiplicity of 
proton 2 changed from a multiplet (at 10 min) to become a double doublet (at 80 min). This 
multiplicity was only due to the coupling with proton 3, while coupling with proton 1 was removed 
by the lactone formation. The combined characterization through MS and NMR approaches of the 
initial reagent, in its hemiacetal form, and of the product(s) resulting as result of the CBR1-
catalyzed process clarified the reaction pathway as mainly yielding glutathionyl-4-hydroxynonanoic 
acid -lactone. 
 
DISCUSSION 
An assessment of the rational basis for the multiplicity of the effects exerted by HNE [26-30]entails 
defining all its metabolic pathways and understanding their importance. Although various enzymes 
are known to directly intervene on HNE, the main step of its detoxification (both in the reductive 
and in the oxidative direction) appears to be mediated by the conjugation with GSH [3], which can 
occur spontaneously or catalyzed by glutathione transferase (GST) isoforms [7,42]. 
Since GSHNE is the most abundant HNE derivative, its metabolism represents the main pathway 
for the control of HNE levels. In this context, GSHNE can be reduced to GS-DHN by aldose 
reductase or oxidized to GSHNA and GSHNA lactone by NAD-dependent aldehyde dehydrogenase 
[54,55]. The data reported in this study add a novel element to this scenario, and demonstrate that 
GSHNE can also be efficiently oxidized to GSHNA lactone by carbonyl reductase 1 (CBR1), a 
well-represented NADP(H)-dependent enzyme in various human cells [78,85]. This enzyme has 
been already reported to catalyze the NADPH-dependent reduction of different endogenous and 
xenobiotic carbonyl compounds [86], including 4-oxononenal (ONE) and its glutathione adduct 
(GS-ONE) [87], thus playing an active role against oxidative stress, neurodegeneration and 
apoptosis [88-92]. However, except for the glutathionyl-NO adduct, endogenous substrate(s) of 
CBR1 have not been successfully identified [93]. 
The protocol optimized for the purification of this GSHNE NADP+ dependent dehydrogenase 
activity from ADF cells led to the isolation of two protein species, migrating with apparent mass of 
31-32 kDa in SDS-PAGE (see Supplementary Fig. 4S). Proteomic analysis identified both proteins 
as human CBR1, also known as NADP+ 15-hydroxyprostaglandine dehydrogenase, and proved 
their migration differences due to the occurrence of a carboxyethyl mojety at Lys238 (see 
Supplementary Fig. 5S).This modification has been already described for the human enzyme and 
has been demonstrated to have no effect on the protein activity and specificity [94,95]. 
The enzyme isolated from ADF cells acts on classical substrates of CBR1, as it is able to reduce 
9,10-PQ, menadione and ONE (Table 1, Fig. 1) and also to oxidize PGB1 (Table 2). A kinetic 
characterization of the ADF GSHNE-DH activity using both PGB1 and GSHNE as substrates 
(Fig.2) revealed a significantly higher efficiency of the enzyme for GSHNE, for which a specificity 
constant was found (12.3 x 103 mM-1 min-1) that was approximately 18-fold higher than PGB1. The 
reduction of prostaglandin A1 by CBR1 has already been reported to be positively affected by the 
presence of a glutathionyl moiety on the molecule [85], which may explain the marked difference 
reported here between GSHNE and PGB1 as substrates to be oxidized. In any case, GSHNE was 
readily and efficiently oxidized by CRB1 in a wide range of pH values (6.5-8.4). 
The time-course evolution of the oxidative products of GSHNE was revealed by a combined MS 
and NMR approach (Figures 4, 5, 7, 8 and 9). The problem of attributing the most abundant 
reaction product with MH+signal at m/z462.23 (Fig. 4B) at the end of the reaction to either 
glutathionyl-4-ketononanal or glutathionyl-4-hydroxynonanoic acid -lactone was solved by NMR, 
which indicated the latter as the main oxidation derivative. In this context, time-course analysis of 
peaks I-IV in NMR spectra (Fig. 8) suggests that II-IV disappeared at the end of the incubation, 
while peak I was still visible. This could indicate that three diastereomers react faster than the one 
corresponding to peak I. According to the chemical shift values previously reported by Balogh et al. 
[81], the lowest-field signal resonating at 5.59 ppm by analogy should correspond to 3S,4R-
GSHNE. Accordingly, we can speculate that the latter species does not properly fit into the CBR1 
active site. A similar condition of diastereoisomer-oriented GSHNE oxidation was also observed 
during nLC-ESI-LIT-MS/MS analysis of the reaction products (see Supplementary Fig. 6S). 
To our knowledge, only one study has reported evidences of a NADP+-dependent oxidation of 
GSHNE as catalyzed by recombinant ALDH3A1 [54]. This enzyme, however, is mainly active on 
HNE and, only to a lesser extent, on GSHNE. On the other hand, the specificity displayed by CRB1 
towards GSHNE with respect to HNE is worth noting, according to the data reported in this study, 
as the latter compound is not processed at all by the enzyme. The identification of GSHNA--
lactone as the main reaction product gives a first conceivable rationale basis for the selective 
recognition of GSHNE by CBR1. Product analysis, in fact, indicates the hydroxyl group of the 
hemiacetal form of the glutathionyl-derivative as a reactive center. This hydroxyl group is derived 
from a structural rearrangement that HNE fails to undergo because of the trans disposition of C4-
hydroxyl and C1-carbonyl groups. However, the occurrence of a hemiacetal hydroxyl group seems 
not a sufficient requirement for enzyme action, since 4-hydroxynonanal, a molecule competent for 
cyclic hemiacetal formation, was not recognized as a substrate (Table 2). These results confirmed 
the importance of the glutathionyl-moiety in tailoring good substrates for CBR1 [85], as it occurs 
for GSHNE. The occurrence of structural restrictions exerted by the glutathionyl moiety present on 
substrates is underlined by the complete lack of action of CBR1 on other HNE-addicted thiol-
containing amino acid and dipeptide substrates, which were tested for the enzyme dehydrogenase 
activity (Table 2). Furthermore, the inability of the enzyme to oxidize GS-nonanal (Table 2) 
indicates that CBR1 does not recognize a substrate containing a free carbonyl moiety, but the 
occurrence of a hemiacetal structure is also required. 
The formation of GSHNA lactone was reported also to occur when GSHNE was incubated with 
cytosolic fractions of murine liver and kidney [55]. On the basis of an experimental inhibition of 
GSHNE oxidation by disulfiram, the oxidative metabolism of GSHNE was associated with a NAD+ 
dependent aldehyde dehydrogenase activity [55]. However, this observation was misleading since 
disulfiram is not a selective inhibitor of ALDHs, but also inhibits CBR1 [96]. Indeed, we have 
measured a 32% inhibition of the purified ADF GSHNE DH activity in the presence of 20 µM 
disulfiram, when the assay was performed in standard assay conditions (data not shown). In 
addition, in dialyzed rat liver extracts GSHNE appears to be oxidized through both a NAD+ and a 
NADP+-dependent reaction (R. Moschini and R. Rotondo, 2014, unpublished results). Finally, a 
NADP+ dehydrogenase activity on GSHNE has recently been found also in human placental, bovine 
kidney and rat testis dialyzed crude extracts (R. Moschini and R. Rotondo, 2014, unpublished 
results). 
As generally occurs with other oxidoreductases, CBR1 efficiently and specifically recognizes 
NADP+ as a cofactor with a KM of 11 µM (Fig. 3). However, the apparent inhibitory effect exerted 
by NADPH on GSHNE oxidation, especially at the NADP+/NADPH ratios present in vivo, raises 
the question on the functional involvement of the GSHNE-DH activity of CBR1 in the GSHNE 
antioxidant metabolic pathways. In fact, the low NADP+/NADPH ratio values generally present in 
normal healthy cells would suggest that CBR1 does not act as a dehydrogenase. However, this 
condition does not concur in cancer cells, where high (or very high) NADP+/NADPH ratios have 
generally been measured. For example, PC3 human prostate cancer cells present a NADP+/NADPH 
value of 2.2, which reaches the apex of 6.5 under glucose deprivation conditions [97]. Similarly, 
breast and colon cancer cells show NADP+/NADPH ratios equal to 5 and 1, respectively, which 
dramatically increase under glucose deprivation conditions in which NADPH became practically 
undetectable [98]. In addition, mutated forms of both the mitochondrial and cytosolic isoforms of 
NADP-dependent isocitrate dehydrogenase, diffusely occurring in glioma and acute myeloid 
leukaemia cells, channel the –ketoglutarate (formed with the concomitant generation of NADPH) 
towards  the formation of 2-hydroxyglutarate with NADPH consumption [99]. 
All these evidences support our proposal for the possible entrance of CBR1 in the enzyme pattern 
(i.e. the pentose phosphate pathway enzymes, isocitrate and malate dehydrogenases) aimed at 
rebuilding the cell-reducing conditions through the NADPH recovery. This role, which seems to 
take place in cancer cells, may also more generally apply to biological systems undergoing 
oxidative stress, where lipid peroxidation takes place. In this context, CBR1 should play a dual role 
in HNE detoxification and in the recovery of the cellular reducing power. In conclusion, the 
efficient and specific NADP+-dependent oxidation of GSHNE to GSHNA--lactone catalyzed by 
CBR1, as shown in this study, suggests another way in HNE breakdown, thus leading to the 
possibility of identifying new strategies for the modulation of the HNE metabolism. 
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Figure captions 
Figure 1. Double reciprocal plot for the reduction of 9,10-PQ by CBR1. 
The initial rate measurements of the NADPH-dependent reduction of 9,10-PQ are reported as 
double reciprocal plot. The assays were performed in standard conditions using 1.2 mU/mL of 
purified CBR1. Error bars represent the standard deviations of the mean from at least three 
independent measurements. 
 
Figure 2.Kinetic analysis of the NADP+ dependent dehydrogenase activity of CBR1. 
The initial rate measurements of the NADP+-dependent oxidation of GSHNE (panel A) and PGB1 
(panel B) are reported as double reciprocal plot. The assays were performed in standard conditions 
using 2.3 mU/mL and 4.6 mU/mL of purified CBR1, respectively. Error bars represent the standard 
deviations of the mean from at least three independent measurements. 
 
Figure 3. Cofactor specificity of CBR1. 
The initial rate of GSHNE oxidation measured at the indicated concentrations of NADP+ alone 
(closed circles), or in the presence of either 10 µM NADPH (squares) or10 µM of NAD+(triangles) 
are reported as double reciprocal plot. The assays were performed in standard conditions using2.3 
mU/mL of purified CBR1. Error bars represent the standard deviations of the mean from at least 
three independent measurements. 
 
Figure 4. Fragmentation spectra of the GSH derivatives observed in this study after their 
collision induced dissociation in positive polarity. 
The fragment nomenclature is identical to that described in Xie et al. [84]. In particular, a=P-
75.032, b=145.061, c=P-146.069, d=P-273.096 or 275.112, e=P-129.043, f=130.050, g=P-232.070, 
h= P-249.095, I =308.091, j=P-307.084 or 305.068, k=274.103, where P represents the [M+H]+ ion 
of the specific GSH conjugate. Panels A, B, C and D show the fragmentation spectrum of the 
species showing a [M+H]+ ion at the experimental m/z value 464.18, 462.23, 480.25 and 478.19, 
respectively. R1, R2, R3 and R4 represent the corresponding neutral losses of C9H16O2 (156.12 Da), 
C9H14O2 (154.10 Da), C9H16O3 (172.11 Da) and C9H14O3 (170.09 Da), respectively. Apart from the 
most intense peak in each presented spectrum, the other regions in the spectra were magnified by a 
factor of 10. To obtain a more certain assignation of the MS2 spectra, several experiments of MS3 
fragmentation were also performed. As an example, Supplementary Fig. 7S shows the MS3 
experiment of the peak at m/z 446.07 in the MS2 spectrum of the original species at m/z 464.18, 
which was assigned to the neutral loss of a single water molecule from the parent ion. 
 
 
Figure 5. Time course of GSHNE oxidation catalyzed by CBR1. 
Plots of peak areas of the species detected at m/z values 464.18, 462.23, 480.25 and 478.19 at 
different times of incubation with CBR1 (panels A to D, respectively), as obtained by the 
integration of the corresponding extracted ion currents in LC-MS runs. 
 
Figure 6. Proposed reaction pathway catalyzed by CBR1. 
The scheme reports possible reaction pathways as deriving from the nature of the products observed 
during time-course nLC-ESI-LIT-MS/MS and NMR analyses of the incubation mixtures. 
 
Figure 7. NMR spectra of single products and their mixtures in phosphate buffer. 
In the GSHNE-GSH-HNE and GSHNE-GSH-HNE-NADP+ spectra (upper and middle), the 
envelope centered at 5.57 ppm was assigned to proton 1 of GSHNE. Four peaks (I at 5.59 ppm, II at 
5.53 ppm, III at 5.50 ppm, and IV at 5.47 ppm) were identified. The remaining proton signals of 
GSHNE were also identified and labeled. 
 
Figure 8. NMR spectra of time course reaction with CBR1 in phosphate buffer. The low field 
region indicates that, in the presence of CBR1, peaks I-IV originating from proton 1 of GSHNE 
start to be modified after 10 min, with all NADPH peaks appearing and the corresponding reduction 
of NAD+. After 80 min peaks II, III and IV almost disappeared, while peak I was still partially 
present, with the doublet at 5.50 ppm originating from NADPH. After 155 min (top spectrum) peak 
I was barely visible. 
 
Figure 9. Lactone identification during the time course reaction with CBR1 in phosphate 
buffer.  
The region between 2.5 and 2.3 ppm comprises the signal of proton 2 of GSHNE. The ongoing 
reaction from 10 min to 155 min indicates that the multiplicity of proton 2 changes from a multiplet 
(at 10 min) to become a double doublet (at 80 min). This multiplicity originates from the coupling 
with proton 3, while coupling with proton 1 is removed by lactone formation. 
 
Highlights 
1) Glutathionyl-hydroxynonanal is susceptible to NADP+-dependent oxidation catalyzed by 
carbonyl reductase. 
2) The glutathionyl-4-hydroxynonanoic acid -lactone is the main product of the reaction. 
3) The reaction may lead to hydroxynonenal detoxification while recovering cell reducing power. 

 
Table 1 Substrate specificity of the NADPH-dependent reductase activity of carbonyl 
reductase.
a
 
Substrate Concentration 
(µM) 
Relative 
activity (%)
b
 
9,10-phenanthrenquinone 40  100 
Menadione 250 48 
4-oxo-nonenal 
 
1000 9 
HNE, GSHNE, glutathione-nonanal, 
trans-2-nonenal
c
. 
 
100 
 
n.d.
d
 
 
a
Enzyme activity was measured as described under Materials and Methods section at the indicated 
substrate concentrations.
 
b
Hundred % of enzyme activity refers to 1.2 mU/mL. 
c
Each compound was individually tested. 
d
n.d. stands for not detectable. 
Table 1
Table 2. Substrate specificity for the NADP
+
-dependent dehydrogenase activity 
of CBR1.
a
 
Substrate Relative rate 
(%)
b
 
GSHNE 
 
100 
PGB1 
 
18 
HNE, 4-hydroxynonanal, 4-oxo-nonenal, 
trans-2-nonenal, CysHNE, CysGlyHNE, 
γ-GutCysHNE , mercapturic acid-HNE, 
GS-nonanal
c
. 
 
n.d.
d
 
 
 
a
Substrate concentration in the assay mixture was 100 µM, with the only exception 
for PGB1 present at 450 µM.  
b
Hundred % activity refers to 2.3 mU/mL.  
c
Each compound was individually tested. 
d
n.d. stands for not detectable. 
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